(Q84409733)

English

Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens

scientific article published on 01 June 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21693238%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21693238%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

based on heuristic

inferred from title

author name string

E Gyurus

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21693238%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Z Kaposztas

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21693238%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

B D Kahan

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21693238%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21693238%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21693238%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21693238%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21693238%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1583-1592

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21693238%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Diabetes mellitus after kidney transplantation in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

New onset diabetes mellitus after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Infections in patients with type 2 diabetes in general practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Posttransplantation diabetes: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Risk factors for posttransplant diabetes mellitus: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Risk factors for development of new-onset diabetes mellitus after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to Cyclosporine-based immunosuppressive regimens in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Individualization of immunosuppressive therapy: I. Sirolimus improves outcomes in African-American renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Steroid sparing in kidney transplantation: changing paradigms, improving outcomes, and remaining questions

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Transplant-associated hyperglycemia: a new look at an old problem

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

New-onset diabetes mellitus after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

New-onset diabetes mellitus after kidney transplantation: the role of immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Insulin regulates lipoprotein lipase activity in rat adipose cells via wortmannin- and rapamycin-sensitive pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Impact of metabolic abnormalities for beta cell function: clinical significance and underlying mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Upstream and downstream of mTOR

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Nonimmunosuppressive effects of mammalian target of rapamycin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.001

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2011.05.001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21693238%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21693238%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84409733&oldid=1513036808"